tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Medicure Reveals Downturn in Q2 2024 Financials

Story Highlights
Medicure Reveals Downturn in Q2 2024 Financials

Medicure (TSE:MPH) has released an update.

Elevate Your Investing Strategy:

Medicure Inc. reported a decrease in total net revenue to $5.2 million in Q2 of 2024, down from $6.0 million in the same quarter the previous year, with significant drops in sales from its AGGRASTAT product due to increased generic competition. The company also experienced a net loss of $1.2 million, a stark contrast to the net income of $253,000 reported in Q2 of 2023.

For further insights into TSE:MPH stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1